Cart
sales@molnova.com
Emorfazone
CAS No. 38957-41-4
Emorfazone( PH011085 )
Catalog No. M24350 CAS No. 38957-41-4
Emorfazone has an anti-nociceptive effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1278 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmorfazone
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmorfazone has an anti-nociceptive effect.
-
DescriptionEmorfazone has an anti-nociceptive effect.
-
In Vitro——
-
In Vivo——
-
SynonymsPH011085
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number38957-41-4
-
Formula Weight239.27
-
Molecular FormulaC11H17N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC(C(N(C)N=C1)=O)=C1N1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Erigeroside
Erigeroside is as a derivatives of -glucose extracted from Satureja khuzistanica Jamzad. Erigerosidehas good ability of anti-oxidation and scavenging oxidation free radical.
-
Mogroside VIB
Mogroside VI B, a cucurbitane glucoside, separated from the crude extract of Siraitia grosvenorii. Mogroside VI B shows effect on activating PGC-1αtranscription.
-
dCeMM1
dCeMM1, a RBM39 glue degrader, re-directs the activity of the CRL4DCAF15 ligase and decreases RBM39 expression levels in WT KBM7 cells.
